^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
obertamig (JNJ-6358)
i
Other names: JNJ-6358, JNJ 78306358, JNJ-78306358
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
J&J, Zymeworks
Drug class:
CD3 agonist, HLA G inhibitor
Related drugs:
Phase 1
Janssen Research & Development, LLC
Completed
Last update posted :
03/24/2023
Initiation :
10/24/2021
Primary completion :
02/09/2023
Completion :
02/09/2023
EGFR • MSI
|
MSI-H/dMMR
|
obertamig (JNJ-6358)
Share
